Aspen Aerogels, Inc. (NYSE:ASPN) Receives $19.11 Average Target Price from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has earned an average recommendation of "Buy" from the ten brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $19.11.

ASPN has been the subject of several research analyst reports. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a report on Friday, February 14th. Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. B. Riley dropped their price target on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research note on Wednesday, February 19th. Finally, TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently modified their holdings of the company. Lord Abbett & CO. LLC purchased a new position in Aspen Aerogels during the 3rd quarter valued at about $10,126,000. Sanders Morris Harris LLC increased its position in Aspen Aerogels by 337.5% during the 4th quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock valued at $436,000 after purchasing an additional 27,000 shares during the period. Vanguard Group Inc. lifted its position in shares of Aspen Aerogels by 5.5% in the 4th quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock worth $51,800,000 after purchasing an additional 226,251 shares during the period. Swiss National Bank boosted its stake in shares of Aspen Aerogels by 1.9% during the 4th quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock valued at $1,530,000 after purchasing an additional 2,400 shares in the last quarter. Finally, Barclays PLC boosted its stake in shares of Aspen Aerogels by 333.8% during the 3rd quarter. Barclays PLC now owns 92,302 shares of the construction company's stock valued at $2,557,000 after purchasing an additional 71,024 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Price Performance

Aspen Aerogels stock traded down $0.24 during midday trading on Wednesday, reaching $5.60. 291,936 shares of the stock were exchanged, compared to its average volume of 1,834,325. The company's fifty day moving average is $6.30 and its 200-day moving average is $11.00. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels has a 52 week low of $4.80 and a 52 week high of $33.15. The firm has a market cap of $459.38 million, a PE ratio of 34.97 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, sell-side analysts forecast that Aspen Aerogels will post 0.17 EPS for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.